|
POLR2D expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.74280000431182E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.07759978296951E-10 |
| Normal-vs-Stage2 |
2.946400E-02 |
| Normal-vs-Stage3 |
4.143300E-03 |
| Normal-vs-Stage4 |
4.176600E-03 |
| Stage1-vs-Stage2 |
1.492240E-01 |
| Stage1-vs-Stage3 |
4.004300E-02 |
| Stage1-vs-Stage4 |
1.640950E-01 |
| Stage2-vs-Stage3 |
9.345000E-01 |
| Stage2-vs-Stage4 |
8.352600E-01 |
| Stage3-vs-Stage4 |
7.276600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.96649999617549E-08 |
| Normal-vs-AfricanAmerican |
1.680770E-01 |
| Normal-vs-Asian |
6.684800E-03 |
| Caucasian-vs-AfricanAmerican |
8.887800E-02 |
| Caucasian-vs-Asian |
2.470100E-02 |
| AfricanAmerican-vs-Asian |
7.377800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32430000000061E-05 |
| Normal-vs-Female |
1.87509996418811E-09 |
| Male-vs-Female |
4.776300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.986380E-01 |
| Normal-vs-Age(41-60Yrs) |
7.32129999958531E-07 |
| Normal-vs-Age(61-80Yrs) |
2.95210000000878E-07 |
| Normal-vs-Age(81-100Yrs) |
1.029790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.161400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.768200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.267400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.571200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.495200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.916800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.340480E-02 |
| Normal-vs-Grade 2 |
4.02080035932784E-10 |
| Normal-vs-Grade 3 |
1.001670E-03 |
| Normal-vs-Grade 4 |
3.620600E-03 |
| Grade 1-vs-Grade 2 |
5.276400E-01 |
| Grade 1-vs-Grade 3 |
1.093840E-01 |
| Grade 1-vs-Grade 4 |
2.762000E-01 |
| Grade 2-vs-Grade 3 |
4.857500E-03 |
| Grade 2-vs-Grade 4 |
2.112400E-01 |
| Grade 3-vs-Grade 4 |
4.577000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.85798076713218E-12 |
| Normal-vs-ccB subtype |
8.961200E-04 |
| ccA subtype-vs-ccB subtype |
1.916680E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.64280000000983E-07 |
| Normal-vs-N1 |
3.743800E-02 |
| N0-vs-N1 |
3.126400E-01 |
|
|
